These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14676944)

  • 21. Importance of GAD65 peptides and I-Ag7 in the development of insulitis in nonobese diabetic mice.
    Ogino T; Sato K; Miyokawa N; Kimura S; Katagiri M
    Immunogenetics; 2000 Jun; 51(7):538-45. PubMed ID: 10912505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells.
    Bridgett M; Cetkovic-Cvrlje M; O'Rourke R; Shi Y; Narayanswami S; Lambert J; Ramiya V; Baekkeskov S; Leiter EH
    Diabetes; 1998 Dec; 47(12):1848-56. PubMed ID: 9836515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of autoimmune diabetes in nonobese diabetic female mice by treatment with recombinant glutamic acid decarboxylase (GAD 65).
    Pleau JM; Fernandez-Saravia F; Esling A; Homo-Delarche F; Dardenne M
    Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):90-5. PubMed ID: 7606872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
    Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
    J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice.
    Baker FJ; Lee M; Chien YH; Davis MM
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9374-9. PubMed ID: 12082183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of novel T-cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice.
    Zechel MA; Elliott JF; Atkinson MA; Singh B
    J Autoimmun; 1998 Feb; 11(1):83-95. PubMed ID: 9480726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
    J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
    Walikonis JE; Lennon VA
    Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
    Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
    Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes.
    Aanstoot HJ; Kang SM; Kim J; Lindsay LA; Roll U; Knip M; Atkinson M; Mose-Larsen P; Fey S; Ludvigsson J; Landin L; Bruining J; Maclaren N; Akerblom HK; Baekkeskov S
    J Clin Invest; 1996 Jun; 97(12):2772-83. PubMed ID: 8675688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with GAD65 or BSA does not protect against diabetes in BB rats.
    Petersen JS; Mackay P; Plesner A; Karlsen A; Gotfredsen C; Verland S; Michelsen B; Dyrberg T
    Autoimmunity; 1997; 25(3):129-38. PubMed ID: 9272278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism.
    Gong Z; Pan L; Le Y; Liu Q; Zhou M; Xing W; Zhuo R; Wang S; Guo J
    Vaccine; 2010 May; 28(24):4052-8. PubMed ID: 20406664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene-gun biolistic immunization encoding glutamic acid decarboxylase: a model for studying Langerhans cell abnormalities and mimicry in the nonobese diabetic mouse.
    Joussemet B; Vu AT; Sai P; Bach JM
    Ann N Y Acad Sci; 2005 Jun; 1051():613-25. PubMed ID: 16127002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of diabetes in NOD mice by GAD65-specific monoclonal antibodies is epitope specific and accompanied by anti-idiotypic antibodies.
    Hall TR; Bogdani M; Leboeuf RC; Kirk EA; Maziarz M; Banga JP; Oak S; Pennington CA; Hampe CS
    Immunology; 2008 Apr; 123(4):547-54. PubMed ID: 18005036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dominant CTL-inducing epitopes on GAD65 are adjacent to or overlap with dominant Th-inducing epitopes.
    Busick RY; Aguilera C; Quinn A
    Clin Immunol; 2007 Mar; 122(3):298-311. PubMed ID: 17174605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of type 1 diabetes in NOD mice knockout for the osteopontin gene.
    Melanitou E
    Gene; 2020 Aug; 753():144785. PubMed ID: 32445922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies specific to the glutamic acid decarboxylase 65 kDa isoform derived from a non-obese diabetic (NOD) mouse.
    Ziegler B; Augstein P; Lühder F; Northemann W; Hamann J; Schlosser M; Klöting I; Michaelis D; Ziegler M
    Diabetes Res; 1994; 25(2):47-64. PubMed ID: 7544254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543).
    Quinn A; Sercarz EE
    J Autoimmun; 1996 Jun; 9(3):365-70. PubMed ID: 8816972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse.
    Wang X; Zhang A; Liu Y; Chen S; Feng Z; Shang W; Maziarz M; Radtke J; Hampe CS
    PLoS One; 2012; 7(2):e32515. PubMed ID: 22384267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.